世界の移植診断市場2026:インサイト・予測

QYResearchが発行した調査報告書(QYR20NV04890)
◆英語タイトル:Global Transplant Diagnostic Market Size, Status and Forecast 2020-2026
◆商品コード:QYR20NV04890
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年11月(※2024年版があります。お問い合わせください。)
◆ページ数:93
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートは移植診断の世界市場について調査・分析した資料です。種類別(移植前診断、移植後診断)の市場規模、用途別(病院、クリニック、リハビリセンター、その他)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別移植診断の競争状況、市場シェア
・世界の移植診断市場:種類別市場規模 2015年-2020年(移植前診断、移植後診断)
・世界の移植診断市場:種類別市場規模予測 2021年-2026年(移植前診断、移植後診断)
・世界の移植診断市場:用途別市場規模 2015年-2020年(病院、クリニック、リハビリセンター、その他)
・世界の移植診断市場:用途別市場規模予測 2021年-2026年(病院、クリニック、リハビリセンター、その他)
・北米の移植診断市場分析:米国、カナダ
・ヨーロッパの移植診断市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの移植診断市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の移植診断市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの移植診断市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Carlyle Group、Immucor、Illumina、Siemens Healthineers、Agilent Technologies
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

Transplant diagnostic is an administrative as well as clinical tool that helps improve operational efficiency of transplantation technique. Transplant diagnostic aids the patients suffering from cancer in order to improve overall operational efficiency as well as patient care.
High prevalence and incidence rates of kidney dysfunction, cardiac diseases, increase in number of cases of lungs disorder and orthopedic injuries in the global population has led to the increase in patient flow to private clinics and hospitals. These factors, collectively, are projected to drive the demand for transplant diagnostic in the near future. Furthermore, the compatibility of markers increases the probability of graft survival and decreases severe immunologic transplant complications, which in turn is estimated to fuel the transplant diagnostic market in the near future.

Market Analysis and Insights: Global Transplant Diagnostic Market
The global Transplant Diagnostic market size is projected to reach US$ 708.1 million by 2026, from US$ 681 million in 2020, at a CAGR of 3.7%% during 2021-2026.

Global Transplant Diagnostic Scope and Market Size
Transplant Diagnostic market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Transplant Diagnostic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Carlyle Group
Immucor
Illumina
Siemens Healthineers
Agilent Technologies

Market segment by Type, the product can be split into
Pre-Transplant Diagnostic
Post-Transplant Diagnostic
Market segment by Application, split into
Hospitals
Clinics
Rehab centers
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Transplant Diagnostic Revenue
1.4 Market by Type
1.4.1 Global Transplant Diagnostic Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Pre-Transplant Diagnostic
1.4.3 Post-Transplant Diagnostic
1.5 Market by Application
1.5.1 Global Transplant Diagnostic Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Rehab centers
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Transplant Diagnostic Market Perspective (2015-2026)
2.2 Global Transplant Diagnostic Growth Trends by Regions
2.2.1 Transplant Diagnostic Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Transplant Diagnostic Historic Market Share by Regions (2015-2020)
2.2.3 Transplant Diagnostic Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Transplant Diagnostic Market Growth Strategy
2.3.6 Primary Interviews with Key Transplant Diagnostic Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Transplant Diagnostic Players by Market Size
3.1.1 Global Top Transplant Diagnostic Players by Revenue (2015-2020)
3.1.2 Global Transplant Diagnostic Revenue Market Share by Players (2015-2020)
3.1.3 Global Transplant Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Transplant Diagnostic Market Concentration Ratio
3.2.1 Global Transplant Diagnostic Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Transplant Diagnostic Revenue in 2019
3.3 Transplant Diagnostic Key Players Head office and Area Served
3.4 Key Players Transplant Diagnostic Product Solution and Service
3.5 Date of Enter into Transplant Diagnostic Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Transplant Diagnostic Historic Market Size by Type (2015-2020)
4.2 Global Transplant Diagnostic Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Transplant Diagnostic Market Size by Application (2015-2020)
5.2 Global Transplant Diagnostic Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Transplant Diagnostic Market Size (2015-2020)
6.2 Transplant Diagnostic Key Players in North America (2019-2020)
6.3 North America Transplant Diagnostic Market Size by Type (2015-2020)
6.4 North America Transplant Diagnostic Market Size by Application (2015-2020)

7 Europe
7.1 Europe Transplant Diagnostic Market Size (2015-2020)
7.2 Transplant Diagnostic Key Players in Europe (2019-2020)
7.3 Europe Transplant Diagnostic Market Size by Type (2015-2020)
7.4 Europe Transplant Diagnostic Market Size by Application (2015-2020)

8 China
8.1 China Transplant Diagnostic Market Size (2015-2020)
8.2 Transplant Diagnostic Key Players in China (2019-2020)
8.3 China Transplant Diagnostic Market Size by Type (2015-2020)
8.4 China Transplant Diagnostic Market Size by Application (2015-2020)

9 Japan
9.1 Japan Transplant Diagnostic Market Size (2015-2020)
9.2 Transplant Diagnostic Key Players in Japan (2019-2020)
9.3 Japan Transplant Diagnostic Market Size by Type (2015-2020)
9.4 Japan Transplant Diagnostic Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Transplant Diagnostic Market Size (2015-2020)
10.2 Transplant Diagnostic Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Transplant Diagnostic Market Size by Type (2015-2020)
10.4 Southeast Asia Transplant Diagnostic Market Size by Application (2015-2020)

11 India
11.1 India Transplant Diagnostic Market Size (2015-2020)
11.2 Transplant Diagnostic Key Players in India (2019-2020)
11.3 India Transplant Diagnostic Market Size by Type (2015-2020)
11.4 India Transplant Diagnostic Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Transplant Diagnostic Market Size (2015-2020)
12.2 Transplant Diagnostic Key Players in Central & South America (2019-2020)
12.3 Central & South America Transplant Diagnostic Market Size by Type (2015-2020)
12.4 Central & South America Transplant Diagnostic Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Carlyle Group
13.1.1 Carlyle Group Company Details
13.1.2 Carlyle Group Business Overview
13.1.3 Carlyle Group Transplant Diagnostic Introduction
13.1.4 Carlyle Group Revenue in Transplant Diagnostic Business (2015-2020))
13.1.5 Carlyle Group Recent Development
13.2 Immucor
13.2.1 Immucor Company Details
13.2.2 Immucor Business Overview
13.2.3 Immucor Transplant Diagnostic Introduction
13.2.4 Immucor Revenue in Transplant Diagnostic Business (2015-2020)
13.2.5 Immucor Recent Development
13.3 Illumina
13.3.1 Illumina Company Details
13.3.2 Illumina Business Overview
13.3.3 Illumina Transplant Diagnostic Introduction
13.3.4 Illumina Revenue in Transplant Diagnostic Business (2015-2020)
13.3.5 Illumina Recent Development
13.4 Siemens Healthineers
13.4.1 Siemens Healthineers Company Details
13.4.2 Siemens Healthineers Business Overview
13.4.3 Siemens Healthineers Transplant Diagnostic Introduction
13.4.4 Siemens Healthineers Revenue in Transplant Diagnostic Business (2015-2020)
13.4.5 Siemens Healthineers Recent Development
13.5 Agilent Technologies
13.5.1 Agilent Technologies Company Details
13.5.2 Agilent Technologies Business Overview
13.5.3 Agilent Technologies Transplant Diagnostic Introduction
13.5.4 Agilent Technologies Revenue in Transplant Diagnostic Business (2015-2020)
13.5.5 Agilent Technologies Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

...

【掲載企業】

Carlyle Group、Immucor、Illumina、Siemens Healthineers、Agilent Technologies

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の移植診断市場2026:インサイト・予測(Global Transplant Diagnostic Market Size, Status and Forecast 2020-2026)]についてメールでお問い合わせはこちらでお願いします。